These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
68 related items for PubMed ID: 21169408
1. Recovery of anoikis in Src-transformed cells and human breast carcinoma cells by restoration of the SIRP α1/SHP-2 signaling system. Hara K, Senga T, Biswas MH, Hasegawa H, Ito S, Hyodo T, Hirooka Y, Niwa Y, Goto H, Hamaguchi M. Cancer Res; 2011 Feb 15; 71(4):1229-34. PubMed ID: 21169408 [Abstract] [Full Text] [Related]
2. Transcriptional regulation of signal regulatory protein alpha1 inhibitory receptors by epidermal growth factor receptor signaling. Kapoor GS, Kapitonov D, O'Rourke DM. Cancer Res; 2004 Sep 15; 64(18):6444-52. PubMed ID: 15374953 [Abstract] [Full Text] [Related]
3. Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs). Wu CJ, Chen Z, Ullrich A, Greene MI, O'Rourke DM. Oncogene; 2000 Aug 17; 19(35):3999-4010. PubMed ID: 10962556 [Abstract] [Full Text] [Related]
4. Negative regulation of hepatocellular carcinoma cell growth by signal regulatory protein alpha1. Yan HX, Wang HY, Zhang R, Chen L, Li BA, Liu SQ, Cao HF, Qiu XH, Shan YF, Yan ZH, Wu HP, Tan YX, Wu MC. Hepatology; 2004 Sep 17; 40(3):618-28. PubMed ID: 15349900 [Abstract] [Full Text] [Related]
5. SIRPalpha1 and SIRPalpha2: their role as tumor suppressors in breast carcinoma cells. Yamasaki Y, Ito S, Tsunoda N, Kokuryo T, Hara K, Senga T, Kannagi R, Yamamoto T, Oda K, Nagino M, Nimura Y, Hamaguchi M. Biochem Biophys Res Commun; 2007 Sep 14; 361(1):7-13. PubMed ID: 17632076 [Abstract] [Full Text] [Related]
7. SIRPalpha1 receptors interfere with the EGFRvIII signalosome to inhibit glioblastoma cell transformation and migration. Kapoor GS, O'Rourke DM. Oncogene; 2010 Jul 22; 29(29):4130-44. PubMed ID: 20473329 [Abstract] [Full Text] [Related]
8. The Shp-2 tyrosine phosphatase activates the Src tyrosine kinase by a non-enzymatic mechanism. Walter AO, Peng ZY, Cartwright CA. Oncogene; 1999 Mar 18; 18(11):1911-20. PubMed ID: 10208413 [Abstract] [Full Text] [Related]
9. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Garcia R, Yu CL, Hudnall A, Catlett R, Nelson KL, Smithgall T, Fujita DJ, Ethier SP, Jove R. Cell Growth Differ; 1997 Dec 18; 8(12):1267-76. PubMed ID: 9419415 [Abstract] [Full Text] [Related]
10. Negatively regulating mechanism of Sirpalpha1 in hepatocellular carcinoma: an experimental study. Qin JM, Yan HX, Liu SQ, Wan XW, Zeng JZ, Cao HF, Qiu XH, Wu MC, Wang HY. Hepatobiliary Pancreat Dis Int; 2006 May 18; 5(2):246-51. PubMed ID: 16698585 [Abstract] [Full Text] [Related]
11. Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Fiucci G, Ravid D, Reich R, Liscovitch M. Oncogene; 2002 Apr 04; 21(15):2365-75. PubMed ID: 11948420 [Abstract] [Full Text] [Related]
12. Delineating v-Src downstream effector pathways in transformed myoblasts. Ciuffini L, Castellani L, Salvati E, Galletti S, Falcone G, Alemà S. Oncogene; 2008 Jan 17; 27(4):528-39. PubMed ID: 17637741 [Abstract] [Full Text] [Related]
13. Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis. Lin X, Gelman IH. Cancer Res; 1997 Jun 01; 57(11):2304-12. PubMed ID: 9187136 [Abstract] [Full Text] [Related]
19. Global effects of anchorage on gene expression during mammary carcinoma cell growth reveal role of tumor necrosis factor-related apoptosis-inducing ligand in anoikis. Goldberg GS, Jin Z, Ichikawa H, Naito A, Ohki M, El-Deiry WS, Tsuda H. Cancer Res; 2001 Feb 15; 61(4):1334-7. PubMed ID: 11245430 [Abstract] [Full Text] [Related]